A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)

Local Institution, Lausanne

Local Institution, Brussels

Local Institution, Brussels

Local Institution, Edegem

Herlev Hospital, Herlev

Local Institution, Leuven

Odense University Hospital, Odense

Local Institution, Innsbruck

Aarhus Universitetshospital, Aarhus

Local Institution, Zurich

NYU Clinical Cancer Center, New York

MSKCC Clinical Laboratory at Nassau, New York

Hopital La Timone, Marseille

Roswell Park Cancer Institute, Buffalo

Hillman Cancer Center, Pittsburgh

Local Institution, Genova

Network Office of Research and Innovation, Allentown

St. Luke'S Health System, Allentown

Local Institution, Milan

Local Institution, Milan

Local Institution, Buxtehude

Local Institution, Lübeck

Local Institution, Bergamo

Duke University Medical Center, Durham

Local Institution, Madrid

Local Institution, Madrid

Levine Cancer Institute, Charlotte

Winship Cancer Institute, Atlanta

Local Institution, Hanover

Local Institution, Pamplona

Orlando Health, Inc, Orlando

Mount Sinai Comprehensive Cancer Center, Miami Beach

H. Lee Moffitt Cancer Center & Research Institute, Tampa

Local Institution, Padua

Tennessee Oncology, PLLC, Nashville

Vanderbilt-Ingram Cancer Center, Nashville

Local Institution, Magdeburg

Local Institution, Nantes

University Hospitals, Cleveland

Local Institution, Essen

Local Institution, Valencia

University Of Michigan Health System, Ann Arbor

Karmanos Cancer Institute, Detroit

Local Institution, Ramat Gan

Local Institution, Siena

Allina Health, Minneapolis

Local Institution, Lille

Local Institution, Frankfurt am Main

Local Institution, Clermont-Ferrand

Washington University School Of Medicine, St Louis

Local Institution, Heidelberg

Local Institution, Pierre-Bénite

Local Institution, Bari

Local Institution, Tübingen

Local Institution, Paris

University Of Colorado, Aurora

Local Institution, Napoli

Local Institution, Munich

Huntsman Cancer Institute, Salt Lake City

Mayo Clinic, Phoenix

The Angeles Clinic & Research Institute, Los Angeles

University Of California - Los Angeles, Los Angeles

Local Institution, Jerusalem

UCSD Moores Cancer Center, La Jolla

San Francisco Oncology Associates, San Francciso

UCSF Comprehensive Cancer Center, San Francisco

Local Institution, Villejuif

Local Institution, Würzburg

Providence Oncology And Hematology, Portland

Yale University School Of Medicine, New Haven

Beth Israel Deaconess Medical Center, Boston

Dana Farber Cancer Institute, Boston

Dana-Farber Cancer Institute, Boston

Local Institution, Vienna

Local Institution, Porto Alegre

Local Institution, Rio de Janeiro

Local Institution, São Paulo

Cross Cancer Institute, Edmonton

Princess Margaret Hospital, Toronto

CHUM, Montreal

Sir Mortimer B Davis - Jewish General Hospital, Montreal

Local Institution, Nice

Local Institution, Dresden

Local Institution, Kiel

Local Institution, Roma

Local Institution, Amsterdam

Local Institution, Groningen

Local Institution, Maastricht

Local Institution, Barcelona

Local Institution, Barcelona

Local Institution, Manchester

Local Institution, Southampton

Local Institution, Oxford

Local Institution, Newcastle upon Tyne

Local Institution, London